- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.03. | AstraZeneca to Acquire Fusion Pharmaceuticals in Potential $2.4B Deal | ||
| 19.03. | AGC Biologics to Manufacture Orchard Therapeutics' Lenmeldy | ||
| 19.03. | Hovione, GEA Advance Continuous Tableting Technology Partnership | ||
| 18.03. | Parexel Announces CEO Transition | ||
| 18.03. | DifGen Acquires FDA-Registered Manufacturing Facility | ||
| 18.03. | Quotient Sciences Makes Executive Leadership Team Appointments | ||
| 18.03. | Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC | ||
| 18.03. | SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility | ||
| 18.03. | BMS Completes $14B Acquisition of Karuna Therapeutics | ||
| 18.03. | Samsung Life Science Fund Invests in BrickBio | ||
| 18.03. | Selvita Adds Antibody Discovery and Development Capabilities | ||
| 15.03. | AAPS Reveals Opening & Closing Plenary Speakers for 2024 National Biotechnology Conference | ||
| 15.03. | LGM Pharma Doubles Down on Analytical Testing, Adds Suppository Manufacturing | ||
| 15.03. | Bormioli Pharma Expands Capacity and Infrastructure for North American Market | ||
| 15.03. | Pace Life Sciences Acquires New Jersey Lab | ||
| 15.03. | Alcami and Tanvex CDMO Partner to Streamline Biologics Development and Manufacturing | ||
| 15.03. | FDA Grants Accelerated Approval for BMS' Breyanzi in CLL, SLL | ||
| 15.03. | Biotheus and Hansoh Pharma Expand Collaboration for Novel Cancer Treatment | ||
| 15.03. | Madrigal Wins Accelerated Approval for NASH Drug Rezdiffra | ||
| 15.03. | CRS Clinical Research Services Appoints Dr. Elisabeth Lackner as CEO | ||
| 15.03. | Borealis AG CEO Thomas Gangl to Depart the Company | ||
| 14.03. | Nuclera Welcomes Joseph Bertelsen as Chief Commercial Officer | ||
| 14.03. | Steriline to Showcase Robotic Vial Filling Machine at INTERPHEX | ||
| 14.03. | Upgraded Syngene Biologics Facility to Be Operational in Second Half of 2024 | ||
| 14.03. | AstraZeneca to Acquire Amolyt Pharma in Potential $1.05B Deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
